大内皮素-1与肥厚型梗阻性心肌病患者心脏重构的相关性分析

来源 :中国循环杂志 | 被引量 : 0次 | 上传用户:klzhang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨血浆大内皮素-1(Big ET-1)水平与肥厚型梗阻性心肌病(HOCM)患者心脏重构的相关性。方法:入选自2015-01至2016-05于我院住院治疗的HOCM患者167例,测定血浆Big ET-1、N末端B型利钠肽原(NT-pro BNP)水平等指标,完善心电图、动态心电图、超声心动图(UCG)及心脏磁共振成像(CMR)检查,进行相关统计学分析。结果:在167例HOCM患者中,相关性分析及多元线性回归发现Ln Big ET-1与Ln NT-pro BNP(r=0.35,P=0.000)、左心房前后径(r=0.169,P=0.019)及心率(r=0.141,P=0.037)呈正相关,与血红蛋白(r=-0.173,P=0.013)及室间隔厚度/左心室后壁厚度比值(r=-0.165,P=0.017)呈负相关。基于Big ET-1与左心房前后径呈正相关的发现,将研究对象分为左心房正常组74例及左心房增大组93例。与左心房正常组比,左心房增大组患者血浆Big ET-1水平显著增高(P=0.001);UCG测量的左心室舒张末期内径较大(P=0.024),室间隔较厚(P=0.003),左心室射血分数偏低(P=0.001);CMR测量的左心室舒张末期容积(P=0.002)及室间隔厚度(P=0.002)较大;伴发心房颤动的比率增加(P=0.004);存在二尖瓣中-大量反流(P=0.011)及纽约心脏协会(NYHA)心功能Ⅲ或Ⅳ级(P=0.022)的患者增多。结论:在HOCM患者中,Ln Big ET-1与Ln NT-pro BNP、左心房内径呈正相关。左心房增大的HOCM患者血浆Big ET-1水平显著升高,心脏结构重构更明显,伴发心房颤动的比率增加。Big ET-1可能在HOCM患者的心脏重构中发挥作用。 Objective: To investigate the correlation between plasma ET-1 level and cardiac remodeling in patients with hypertrophic obstructive cardiomyopathy (HOCM). Methods: One hundred and sixty-seven HOCM patients admitted to our hospital from January 2015 to 2016-05 were enrolled in this study. The plasma ET-1 and NT-proBNP levels were measured. The electrocardiogram, Holter, echocardiography (UCG) and cardiac magnetic resonance imaging (CMR) examination, the relevant statistical analysis. Results: In 167 patients with HOCM, correlation analysis and multiple linear regression showed that Ln Big ET-1 and Ln NT-pro BNP (r = 0.35, P = 0.000) ) And heart rate (r = 0.141, P = 0.037), and negatively correlated with hemoglobin (r = -0.173, P = 0.013) and ventricular septal thickness / left ventricular posterior wall thickness Related. Based on the positive correlation between Big ET-1 and anteroposterior diameter of left atrium, the subjects were divided into 74 cases of normal left atrium and 93 cases of left atrial enlargement. Compared with the normal left atrium group, the plasma levels of Big ET-1 in patients with left atrial enlargement were significantly increased (P = 0.001). The diameter of left ventricular end-diastolic diameter measured by UCG was larger (P = 0.024) and the ventricular septum thicker (P = 0.003), left ventricular ejection fraction (P = 0.001), left ventricular end diastolic volume (P = 0.002) and interventricular septum thickness (P = 0.002) = 0.004). There was an increase in patients with moderate-mitral regurgitation (P = 0.011) and NYHA cardiac function grade III or IV (P = 0.022). CONCLUSION: Ln Big ET-1 and Ln NT-pro BNP and left atrial diameter are positively correlated in patients with HOCM. The plasma levels of Big ET-1 in patients with HOCM with increased left atrium were significantly increased, the structural remodeling of the heart was more pronounced, and the rate of atrial fibrillation was increased. Big ET-1 may play a role in cardiac remodeling in HOCM patients.
其他文献
脂蛋白相关磷脂酶A2(Lp-PLA2)由炎症细胞产生,可以水解氧化型低密度脂蛋白(ox-LDL)产生炎症介质促进动脉粥样硬化。Lp-PLA2存在于不稳定斑块以及破裂斑块中,与急性冠状动脉综合征的
目的:观察分娩镇痛对产妇产程的影响,并采取有效措施给予护理。方法138例孕妇,按照是否选择镇痛意愿分成观察组及对照组,每组69例。观察组给予分娩镇痛,对照组不给予分娩镇痛,观察
对于急性冠状动脉综合征(ACS)及经皮冠状动脉介入治疗(PCI)围术期患者,血小板减少可增加缺血及出血并发症的风险,从而影响临床结局。但由于血小板减少在PCI围术期发生率较低,未能在
长链非编码核糖核酸(lncRNA)是一类长度大于200 nt的非编码核糖核酸(RNA),它参与多种细胞生命活动和疾病的进展。由于科学技术的飞速发展,高通量测序以及微阵列技术的成熟,lncRNA在
氯吡格雷是治疗急性冠状动脉综合征(ACS)、预防经皮冠状动脉介入治疗(PCI)后支架内血栓和再发缺血事件的基石药物。细胞色素CYP2C19基因对氯吡格雷疗效起一定作用,携带CYP2C19*2和
目的:对经皮肾镜碎石取石术患者术后的护理问题进行解析并探讨对策。方法对116例经皮肾镜碎石取石术患者的临床治疗和护理方法进行分析。结果104例一次手术结石完全清除,12例
目的:观察“分站式”杂交冠状动脉血运重建术(HCR)治疗冠状动脉多支血管病变中期随访结果,评价“分站式”HCR的可行性、安全性和疗效。  方法:入选2012-01至2014-06因冠状动脉多
前言rn为了加强对经外科途径心血管疾病介入诊疗技术的管理及质量控制工作,原卫生部于2012年成立经外科途径心血管疾病介入诊疗专家工作组,该工作组由国内著名心血管外科专家
期刊
目的:分析研究脑栓塞后抑郁患者行护理干预的临床疗效。方法92例脑栓塞后抑郁患者,根据护理方法不同划分为对照组和观察组,对照组52例采用日常护理,观察组40例采用护理干预,分析对
目的:探讨不同护理模式对老年急性胃穿孔患者手术效果及预后的影响。方法急性胃穿孔手术治疗的60例患者随机分为路径组和常规组,每组30例。常规组采用常规护理;路径组实施路径护